RecruitingNCT06983366

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases: A Prospective Case-Control Study


Sponsor

Assiut University

Enrollment

700 participants

Start Date

May 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age 18 years and older.
  • Diagnosed with one of the specified pulmonary diseases, or a healthy control
  • Able to provide written informed consent

Exclusion Criteria5

  • Inability to tolerate or undergo a lung ultrasound
  • Extensive chest wall pathology precluding assessment
  • Unscorable \>2 zones per protocol
  • Withdrawal of consent
  • Mechanically-ventilated patients

Interventions

DIAGNOSTIC_TESTLung Ultrasound

All enrolled patient will be subjected to Lung Ultrasound examination LUS


Locations(1)

Assiut University- Faculty of Medicine

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06983366


Related Trials